Literature DB >> 33462123

Modes of Regulated Cell Death in Cancer.

Elle Koren1, Yaron Fuchs2.   

Abstract

Cell suicide pathways, termed regulated cell death (RCD), play a critical role in organismal development, homeostasis, and pathogenesis. Here, we provide an overview of key RCD modalities, namely apoptosis, entosis, necroptosis, pyroptosis, and ferroptosis. We explore how various RCD modules serve as a defense mechanism against the emergence of cancer as well as the manner in which they can be exploited to drive oncogenesis. Furthermore, we outline current therapeutic agents that activate RCD and consider novel RCD-based strategies for tumor elimination. SIGNIFICANCE: A variety of antitumor therapeutics eliminate cancer cells by harnessing the devastating potential of cellular suicide pathways, emphasizing the critical importance of RCD in battling cancer. This review supplies a mechanistic perspective of distinct RCD modalities and explores the important role they play in tumorigenesis. We discuss how RCD modules serve as a double-edged sword as well as novel approaches aimed at selectively manipulating RCD for tumor eradication. ©2021 American Association for Cancer Research.

Entities:  

Mesh:

Year:  2021        PMID: 33462123     DOI: 10.1158/2159-8290.CD-20-0789

Source DB:  PubMed          Journal:  Cancer Discov        ISSN: 2159-8274            Impact factor:   39.397


  47 in total

Review 1.  The Apoptosis Paradox in Cancer.

Authors:  Ornella Morana; Will Wood; Christopher D Gregory
Journal:  Int J Mol Sci       Date:  2022-01-25       Impact factor: 5.923

Review 2.  Methodological Approaches for Assessing Metabolomic Changes in Glioblastomas.

Authors:  Trang T T Nguyen; Enyuan Shang; Mike-Andrew Westhoff; Georg Karpel-Massler; Markus D Siegelin
Journal:  Methods Mol Biol       Date:  2022

Review 3.  Breast cancer: molecular mechanisms of underlying resistance and therapeutic approaches.

Authors:  Muhammad Tufail; Jia Cui; Changxin Wu
Journal:  Am J Cancer Res       Date:  2022-07-15       Impact factor: 5.942

Review 4.  Protein tyrosine kinase inhibitor resistance in malignant tumors: molecular mechanisms and future perspective.

Authors:  Yang Yang; Shuo Li; Yujiao Wang; Yi Zhao; Qiu Li
Journal:  Signal Transduct Target Ther       Date:  2022-09-17

Review 5.  Naturally derived indole alkaloids targeting regulated cell death (RCD) for cancer therapy: from molecular mechanisms to potential therapeutic targets.

Authors:  Rui Qin; Feng-Ming You; Qian Zhao; Xin Xie; Cheng Peng; Gu Zhan; Bo Han
Journal:  J Hematol Oncol       Date:  2022-09-14       Impact factor: 23.168

Review 6.  Autophagy, ferroptosis, pyroptosis, and necroptosis in tumor immunotherapy.

Authors:  Weitong Gao; Xueying Wang; Yang Zhou; Xueqian Wang; Yan Yu
Journal:  Signal Transduct Target Ther       Date:  2022-06-20

Review 7.  Roles and Mechanisms of Regulated Necrosis in Corneal Diseases: Progress and Perspectives.

Authors:  Wanying Lin; Minting Chen; Yacouba Cissé; Xiaofeng Chen; Lang Bai
Journal:  J Ophthalmol       Date:  2022-05-23       Impact factor: 1.974

8.  Stem Cell Factor SOX2 Confers Ferroptosis Resistance in Lung Cancer via Upregulation of SLC7A11.

Authors:  Xinbo Wang; Yueqing Chen; Xudong Wang; Hongling Tian; Yanjin Wang; Jiali Jin; Zezhi Shan; Yu'e Liu; Zhenyu Cai; Xinyuan Tong; Yi Luan; Xiao Tan; Bing Luan; Xin Ge; Hongbin Ji; Xuejun Jiang; Ping Wang
Journal:  Cancer Res       Date:  2021-08-12       Impact factor: 12.701

9.  Understanding the role of cysteine in ferroptosis: progress & paradoxes.

Authors:  Carson D Poltorack; Scott J Dixon
Journal:  FEBS J       Date:  2021-04-07       Impact factor: 5.542

10.  Identification of a Ferroptosis-Related LncRNA Signature as a Novel Prognosis Model for Lung Adenocarcinoma.

Authors:  Lu Lu; Le-Ping Liu; Qiang-Qiang Zhao; Rong Gui; Qin-Yu Zhao
Journal:  Front Oncol       Date:  2021-06-23       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.